Retrouvez les posters et communications orales qui ont été présentés aux éditions 2022 de l’ASCO et l’EHA.
| Poster FLIRT | ASCO 2022 |
|---|---|
| Guillaume Cartron | Subcutaneous rituximab induction followed by short rituximab maintenance to improve progression-free survival in patients with low-tumor burden follicular lymphoma: Final results of FLIRT phase III trial, a LYSA study |
| Présentations orales DESCAR-T | EHA 2022 |
|---|---|
| Emmanuel Bachy | A matched comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory Diffuse Large B-cell Lymphoma: a real-life LYSA study from the French DESCAR-T registry |
| Pierre Sesques | CAR T-cells associated acute toxicity in B-cell Non-Hodgkin Lymphoma: real-world study from the DESCAR-T registry |
| Poster REALYSA | EHA 2022 |
|---|---|
| Hervé Ghesquières | A large French real world multicentric prospective cohort of patients with lymphoma (REALYSA study): description of the Diffuse Large B-cell Lymphoma patients in real world in France |
| Poster FLIRT | EHA 2022 |
|---|---|
| Guillaume Cartron | Subcutaneous rituximab induction followed by short rituximab maintenance to improve progression-free survival in patients with low-tumor burden follicular lymphoma: Final results of FLIRT phase III trial, a LYSA study |
| Poster | EHA 2022 |
|---|---|
| Loïc Renaud | Intrathecal Methotrexate prophylaxis and Central Nervous System relapse in patients with Diffuse Large B-cell Lymphoma treated with intensified R-ACVBP strategy |